isomethyleugenol has been researched along with pirenzepine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kramss, RH; Mangano, RM; Trybulski, EJ; Zhang, J | 1 |
| Andrews, JS; de Boer, T; Gibson, S; Plate, R; Plaum, MJ; Rae, DR | 1 |
2 other study(ies) available for isomethyleugenol and pirenzepine
| Article | Year |
|---|---|
The synthesis and biochemical pharmacology of enantiomerically pure methylated oxotremorine derivatives.
Topics: Animals; Binding, Competitive; Cerebral Cortex; Guanylyl Imidodiphosphate; Male; Methylation; N-Methylscopolamine; Oxotremorine; Pirenzepine; Quinuclidinyl Benzilate; Rats; Rats, Wistar; Receptors, Muscarinic; Scopolamine Derivatives; Stereoisomerism | 1993 |
Synthesis and muscarinic activities of 3-(pyrazolyl)-1,2,5,6-tetrahydropyridine derivatives.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alzheimer Disease; Analysis of Variance; Animals; Binding, Competitive; Disease Models, Animal; Dopamine Agents; Isotope Labeling; Male; Memory; Methylation; Mice; Miosis; Muscarinic Agonists; Muscarinic Antagonists; Mydriasis; Oxotremorine; Pirenzepine; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Salivation; Structure-Activity Relationship; Vas Deferens | 1996 |